Opportunity ID: 269575

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-14-066
Funding Opportunity Title: Non-Traditional Therapeutics that Limit Antibacterial Resistance (R21/R33)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 14, 2014
Last Updated Date:
Original Closing Date for Applications: Feb 23, 2015
Current Closing Date for Applications: Feb 23, 2015
Archive Date: Mar 26, 2015
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Independent school districts
City or township governments
Public and State controlled institutions of higher education
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
County governments
Special district governments
Private institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement is to solicit applications for early-stage translational research projects focused on discovery and development of novel non-traditional therapeutics that provide alternative treatment modalities for infected patients and address the growing health care threat of increasing antibiotic resistance.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-066.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00209873 Jan 23, 2015 Feb 23, 2015 View

Package 1

Mandatory forms

269575 RR_SF424_2_0-2.0.pdf

269575 PHS398_ResearchPlan_2_0-2.0.pdf

269575 PHS398_CoverPageSupplement_2_0-2.0.pdf

269575 RR_Budget_1_3-1.3.pdf

269575 RR_KeyPersonExpanded_2_0-2.0.pdf

269575 RR_OtherProjectInfo_1_3-1.3.pdf

269575 PerformanceSite_2_0-2.0.pdf

Optional forms

269575 PlannedReport-1.0.pdf

269575 PHS398_CumulativeInclusionReport-1.0.pdf

269575 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-09T20:11:34-05:00

Share This Post, Choose Your Platform!

About the Author: